2011 Anniversary Yearbook - EUFEPS today and history

Objective 5
To enhance the recognition of the
pharma ceutical sciences and to
contribute appropria tely to public
policy relevant to drug research and
development, drug regulation and
drug utilization, with EUFEPS as the
primary voi cing organisation at the
European level.
This is a tough objective to meet, but we are
making headway through the activities of
the Committee on Pharmaceutical Policy,
which organise some of the Nuremberg
Con ferences. One positive step has been
our con tact with various European bodies,
such as the EMEA in London, making
those aware of our contribution to debates
on scientific issues and policy pertinent to
the European pharma ceutical arena.
Although not explicitlytated in the
1994–1998 strategic document, implicitly
training and education in research,
interfacing with industry, and finance
are central to the suc cess of EUFEPS.
Training was identified by the Committee
of Industrial Relationships (CIR) as an
urgent and critical need that we must
address seriously in the coming years, in
partnership with industry and academia.
Here our Corporate Membership, which
continues to gro, We do, however, need
to make even more extensive contacts and
have among our membership a greater
number of industrial pharmaceutical
scientists.
Finally,
underpinning all our activities is sound
finance, without which we cannot continue.
Since its inception, with limited resource,
EUFEPS has been financially dependent
on the gene rosity and foresightedness of
the Swedish Academy of Pharmaceutical
Sciences. While gratefully received and
acknowledged, the strategy has been to
continually diminish this dependency
such that by 1998 EUFEPS will be
financially independent. With a string of
successful meetings, rising membership
and increasing subscription to EJPS, I am
confi dent that we will meet this objective
on time, so enabling us to look forward
with confidence to an ever successful
future. I sincerely hope that you share my
enthusiasm and optimism for the future
of EUFEPS. With your help, together we
cannot fail.
XIV